A unified research environment integrating scientific literature, molecular datasets, and AI-driven reasoning to accelerate insight.
AI-powered synthesis of 38M+ biomedical publications. Real-time PubMed, ClinicalTrials.gov, and FDA alerts on any research topic.
3-level intelligence: known cancer treatment, unknown cancer fingerprinting, and pan-cancer tumour-agnostic therapy — 28 cancer types, 14 analysis modules.
Kaplan-Meier survival curves, mutation landscapes, pathway heatmaps, basket trial matching, and exportable clinical reports.
Open Onexa integrates scientific literature, molecular datasets, and AI-driven reasoning into a unified research environment designed to accelerate insight.
Synthesize complex biomedical papers into structured insights. Auto-scan PubMed, ClinicalTrials.gov, and FDA for new findings relevant to your research.
Level 1: known cancer → targeted treatment. Level 2: unknown cancer → fingerprint mutations across 28 types. Level 3: novel case → pan-cancer actionable targets and basket trials.
VAF, actionable variants, IO prediction, DDR, pathways, germline risk, TME, fusions, CNA, synthetic lethality, drug combos, prognosis, trial matching, resistance — all in one platform.
Auto-generate dark-themed HTML/PDF reports covering every genomic module. Export cohort data as XLSX, PPTX, or JSON. Timeline tracking and multi-cohort comparison.
Whether you have a confirmed diagnosis, an unclassified tumour, or a completely novel case, the platform generates treatment guidance and research directions.
Targeted Treatment
Molecular Fingerprinting
Treat the Mutation
Open Onexa is initiating focused pilot collaborations to validate its AI research intelligence engine in live research environments.
Integrating AI-powered insight into laboratory workflows. Designed for research teams working on complex biomedical challenges.
Accelerating hypothesis generation in niche oncology fields. Purpose-built tools for rare cancer discovery.
Open Onexa was founded with a singular purpose: to accelerate rare cancer discovery by reducing friction in scientific exploration. We believe artificial intelligence should empower researchers — not replace them.
Advancing discovery through intelligent infrastructure.
Your research data is protected by industry-leading security measures.
TLS 1.3 in transit, AES-256 at rest. Your data is encrypted at every layer.
Role-based permissions with multi-factor authentication support.
GDPR-aligned data governance with full audit trails and data sovereignty.